6c3fd2dd__Trials_Monthly___October_2013__Description
[NCI Designation] NCT01266031 [Disease Site] Glioblastoma [Description] 
Phase I/II Adaptive Randomized Trial of Bevacizumab versus Bevacizumab Plus Vorinostat in Adults with Recurrent Glioblastoma
Seattle Cancer Care Alliance | Clinical Trials Monthly - October 2013
Description